Research Leaders / KOL Map

Ulcerative Colitis: Research Leaders and Landscape

The most active researchers, institutions, and subtopics in Ulcerative Colitis, from recent PubMed records. Public authorship only, every figure verifiable by PMID.

Analyzed 375 recent PubMed papers (2021-2026) matching "ulcerative colitis biologic JAK inhibitor". Source: NLM PubMed. Generated July 2026.

Top research leaders (by recent publication volume)

#ResearcherAffiliationPapers
1Peyrin-Biroulet LaurentUniversity of Lorraine23
2Danese SilvioIRCCS Ospedale San Raffaele and University Vita-Salute San22
3Jairath VipulWestern University17
4Schreiber StefanUniversity Hospital Schleswig-Holstein12
5Hibi ToshifumiKitasato University Kitasato Institute Hospital11
6Vermeire SéverineUniversity Hospitals Leuven10
7Ma ChristopherUniversity of Calgary9
8Saruta MasayukiThe Jikei University School of Medicine8
9Singh SiddharthUniversity of California San Diego8
10D'Amico FerdinandoIRCCS Ospedale San Raffaele and Vita-Salute San Raffaele U8
11Armuzzi AlessandroIRCCS Humanitas Research Hospital7
12Panaccione RemoUniversity of Calgary7
13D'Haens GeertAmsterdam University Medical Centres7
14Oortwijn AlessandraGalapagos NV7
15Hisamatsu TadakazuKyorin University School of Medicine6
16Amiot AurélienHopitaux Universitaires Bicêtre6
17Chaparro MaríaHospital Universitario de La Princesa6
18Narula NeerajMcMaster University6

Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.

Leading institutions

Western University (18), University Hospitals Leuven (14), Pfizer Inc (14), Mayo Clinic (11), University of Calgary (11), Kitasato University Kitasato Institute Hospital (10), University of California San Diego (10), University of Lorraine (10), University Hospital Schleswig-Holstein (9), Galapagos NV (9)

Active subtopics

Colitis, Ulcerative (223), Piperidines (128), Pyrimidines (127), Janus Kinase Inhibitors (108), Treatment Outcome (102), Inflammatory Bowel Diseases (78), Remission Induction (56), Biological Products (49), Retrospective Studies (48)

Top journals

Inflammatory bowel diseases (36), Journal of Crohn's & colitis (28), Alimentary pharmacology & therapeutics (13), Cureus (10), Intestinal research (10), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association (10)

Representative recent papers

Upadacitinib in Biologic-Naïve Patients With Acute Severe Ulcerative Colitis: A Case Report of a Promising Alternative Rescue Ther (2026) · PMID 42441167

Comparative efficacy of advanced therapies in biological-exposed ulcerative colitis - a network meta-analysis of randomized trials (2026) · PMID 42429193

Efficacy and safety of ozanimod in Japanese patients with moderately to severely active ulcerative colitis naive to immunomodulato (2026) · PMID 42427283

Update on Pregnancy in Inflammatory Bowel Disease. (2026) · PMID 42389327

Advanced therapies in management of pediatric inflammatory bowel disease. (2026) · PMID 42361097

Want the full cited brief?

A full Ulcerative Colitis brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.

Try the live tool Contact us